These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 26595229)

  • 1. Experiences of Kratom Users: A Qualitative Analysis.
    Swogger MT; Hart E; Erowid F; Erowid E; Trabold N; Yee K; Parkhurst KA; Priddy BM; Walsh Z
    J Psychoactive Drugs; 2015; 47(5):360-7. PubMed ID: 26595229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kratom use and mental health: A systematic review.
    Swogger MT; Walsh Z
    Drug Alcohol Depend; 2018 Feb; 183():134-140. PubMed ID: 29248691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case report of inpatient detoxification after kratom (Mitragyna speciosa) dependence.
    McWhirter L; Morris S
    Eur Addict Res; 2010; 16(4):229-31. PubMed ID: 20798544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kratom: Implications for Health Care Providers.
    Goldin D; Salani D; Mckay M
    J Psychosoc Nurs Ment Health Serv; 2019 Dec; 57(12):15-20. PubMed ID: 31774129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa).
    Hartley C; Bulloch M; Penzak SR
    J Clin Pharmacol; 2022 May; 62(5):577-593. PubMed ID: 34775626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users.
    Singh D; Müller CP; Vicknasingam BK
    Drug Alcohol Depend; 2014 Jun; 139():132-7. PubMed ID: 24698080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kratom (Mitragyna speciosa): Friend or Foe?
    Sethi R; Hoang N; Ravishankar DA; McCracken M; Manzardo AM
    Prim Care Companion CNS Disord; 2020 Jan; 22(1):. PubMed ID: 31999896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia.
    Singh D; Müller CP; Murugaiyah V; Hamid SBS; Vicknasingam BK; Avery B; Chear NJY; Mansor SM
    J Ethnopharmacol; 2018 Mar; 214():197-206. PubMed ID: 29248450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.
    Prozialeck WC; Jivan JK; Andurkar SV
    J Am Osteopath Assoc; 2012 Dec; 112(12):792-9. PubMed ID: 23212430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia.
    Singh D; Narayanan S; Vicknasingam B; Corazza O; Santacroce R; Roman-Urrestarazu A
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28544011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries.
    Cinosi E; Martinotti G; Simonato P; Singh D; Demetrovics Z; Roman-Urrestarazu A; Bersani FS; Vicknasingam B; Piazzon G; Li JH; Yu WJ; Kapitány-Fövény M; Farkas J; Di Giannantonio M; Corazza O
    Biomed Res Int; 2015; 2015():968786. PubMed ID: 26640804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating health information provided to kratom consumers by good manufacturing practice-qualified vendors.
    Hill K; Gibson S; Grundmann O; Smith KE; Ballard J; Stanciu CN
    Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):21. PubMed ID: 37041624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.
    Warner ML; Kaufman NC; Grundmann O
    Int J Legal Med; 2016 Jan; 130(1):127-38. PubMed ID: 26511390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of gonadotropins and testosterone hormone levels in regular Mitragyna speciosa (Korth.) users.
    Singh D; Murugaiyah V; Hamid SBS; Kasinather V; Chan MSA; Ho ETW; Grundmann O; Chear NJY; Mansor SM
    J Ethnopharmacol; 2018 Jul; 221():30-36. PubMed ID: 29626673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kratom abuse in Ramathibodi Poison Center, Thailand: a five-year experience.
    Trakulsrichai S; Tongpo A; Sriapha C; Wongvisawakorn S; Rittilert P; Kaojarern S; Wananukul W
    J Psychoactive Drugs; 2013; 45(5):404-8. PubMed ID: 24592666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of urinary protein profile in regular kratom (
    Jasim RK; Hassan Z; Singh D; Boyer E; Gam LH
    J Addict Dis; 2022; 40(2):235-246. PubMed ID: 34747343
    [No Abstract]   [Full Text] [Related]  

  • 17. Severity of Pain and Sleep Problems during Kratom (Mitragyna speciosa Korth.) Cessation among Regular Kratom Users.
    Singh D; Narayanan S; Vicknasingam BK; Prozialeck WC; Ramanathan S; Zainal H; Harun SN
    J Psychoactive Drugs; 2018; 50(3):266-274. PubMed ID: 29558272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.
    Fowble KL; Musah RA
    Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Cognitive Effects of Kratom (Mitragyna speciosa Korth.) Use.
    Singh D; Narayanan S; Müller CP; Vicknasingam B; Yücel M; Ho ETW; Hassan Z; Mansor SM
    J Psychoactive Drugs; 2019; 51(1):19-27. PubMed ID: 30556488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the self-reported motivations of kratom (
    Grundmann O; Veltri CA; Morcos D; Knightes D; Smith KE; Singh D; Corazza O; Cinosi E; Martinotti G; Walsh Z; Swogger MT
    Am J Drug Alcohol Abuse; 2022 Jul; 48(4):433-444. PubMed ID: 35389321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.